Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. SkinBioTherapeutics Plc
  6. Summary
    SBTX   GB00BF33H870

SKINBIOTHERAPEUTICS PLC

(SBTX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
09/13/2021 09/14/2021 09/15/2021 09/16/2021 09/17/2021 Date
63(c) 60(c) 59.5(c) 60(c) 61(c) Last
577 063 405 323 270 852 111 945 169 927 Volume
+2.44% -4.76% -0.83% +0.84% +1.67% Change
More quotes
Estimated financial data (e)
Sales 2021 - - -
Net income 2021 -2,11 M -2,90 M -2,90 M
Net cash position 2021 3,40 M 4,67 M 4,67 M
P/E ratio 2021 -42,4x
Yield 2021 -
Sales 2022 1,17 M 1,61 M 1,61 M
Net income 2022 -1,85 M -2,54 M -2,54 M
Net cash position 2022 1,50 M 2,06 M 2,06 M
P/E ratio 2022 -51,3x
Yield 2022 -
Capitalization 95,6 M 132 M 131 M
EV / Sales 2021 -
EV / Sales 2022 80,5x
Nbr of Employees 7
Free-Float 55,2%
More Financials
Company
SkinBioTherapeutics PLC is a life science company focused on skin health. The Company’s platform technology, SkinBiotix, applies research discoveries made on the activities of lysates derived from probiotic bacteria when applied to skin. The Company’s SkinBiotix platform can improve the barrier effect of skin models, improve repair and reduce bacterial load. It focuses on three specific skin healthcare sectors:... 
More about the company
All news about SKINBIOTHERAPEUTICS PLC
08/19SkinBioTherapeutics Provides Update on Plans for Commercialization of AxisBio..
CI
05/26SKINBIOTHERAPEUTICS : Positive data for AxisBiotix-Ps™ food supplement con..
PU
04/27SKINBIOTHERAPEUTICS : Initiation of oral health development programme | 27 April..
PU
04/27SKINBIOTHERAPEUTICS : New oral health research programme initiated with the Univ..
PU
04/27SKINBIOTHERAPEUTICS : New research agreement initiated with the University of Ma..
PU
04/08Skinbiotherapeutics plc Initiates A Research Programme with the University of..
CI
04/07SKINBIOTHERAPEUTICS : Research programme with University of Manchester | 08 Apri..
PU
03/15Skinbiotherapeutics plc Reports Earnings Results for the Half Year Ended Dece..
CI
01/13SKINBIOTHERAPEUTICS : Subsidiary AxisBiotix To Start Studies On Psoriasis Treatm..
MT
2020SKINBIOTHERAPEUTICS : Earnings Flash (SBTX.L) SKINBIOTHERAPEUTICS Posts FY20 EPS..
MT
2020Skinbiotherapeutics plc Reports Earnings Results for the Full Year Ended June..
CI
2020SKINBIOTHERAPEUTICS : Half Year Results
PU
2020Skinbiotherapeutics plc Reports Earnings Results for the Half Year Ended Dece..
CI
2020SKINBIOTHERAPEUTICS : signs agreement with Winclove Probiotics to develop psoria..
PU
2019Skinbiotherapeutics plc Reports Earnings Results for the Full Year Ended June..
CI
More news
News in other languages on SKINBIOTHERAPEUTICS PLC

- No features available -

More news
Chart SKINBIOTHERAPEUTICS PLC
Duration : Period :
SkinBioTherapeutics Plc Technical Analysis Chart | SBTX | GB00BF33H870 | MarketScreener
Technical analysis trends SKINBIOTHERAPEUTICS PLC
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 0,61 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Stuart John Ashman Chief Executive Officer & Director
Douglas John Quinn Chief Financial Officer, Secretary & Director
Martin Braddock Hunt Non-Executive Chairman
Catherine Anne O'Neill Chief Scientific Officer
Stephen Patrick O'Hara Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
SKINBIOTHERAPEUTICS PLC159.57%132
GILEAD SCIENCES, INC.22.91%89 785
BIONTECH SE340.60%86 750
WUXI APPTEC CO., LTD.35.75%69 350
REGENERON PHARMACEUTICALS34.93%67 775
VERTEX PHARMACEUTICALS-20.33%48 850